Purchase of Geister Peripheral and Major Vascular Access Instruments

Cardiff and Vale University Health BoardcontractFind a TenderRef ocds-h6vhtk-06845bProcurement Act 2023pending
View buyer

Estimated value

Awarded value

£95k

Suppliers

1

Lots

1

1 awarded

Published

16 Apr 2026

Description

Cardiff and Vale University Health Board, intends to award a contract to Medivate for the one off purchase of Geister Peripheral and Major Vascular Access Instruments. The University Hospital of Wales (UHW) operates as a Major Trauma Centre and provides regional vascular and trauma services, receiving referrals from across South and West Wales. Theatre capacity is being expanded, including the development of additional major trauma and hybrid theatres to support high‑complexity trauma and vascular surgery. Peripheral and major vascular instrument sets are required for use across multiple theatre settings, including elective vascular theatres, CEPOD emergency theatres, Major Trauma Centre theatres, and hybrid/endovascular suites. These instrument sets support the delivery of abdominal aortic repairs, carotid endarterectomies, lower limb revascularisation procedures, trauma‑related vascular repairs, and conversions from endovascular to open surgery. The existing instrument inventory currently comprises three major vascular sets and four peripheral sets, which are fully utilised for elective, endovascular, and reserved damage‑control activity. This utilisation limits availability for urgent and out‑of‑hours procedures. The procurement of additional instrument trays is required to maintain operational capacity, ensure cover for emergency, weekend, and trauma activity, and support continuity of elective services across planned and unplanned care pathways.

Scope

Reference
CAV-DCO-(26-27) 4
Commercial tool
Standalone contract

Submission & procedure

Procedure
Direct award

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£95k

Award date

Contract start

30 Apr 2026

Contract end

30 Jun 2026

Awarded to